symplr Earns U.S. Best Managed Company Designation for Second Consecutive Year
Award highlights symplr's culture, operational excellence & innovation with symplr Operations Platform
symplr was recognized for demonstrating excellence in strategic planning and execution, a deep commitment to employees, and maintaining strong financial performance and governance. The company propelled business growth while prioritizing employees and delivering exceptional value to customers. By leveraging advanced technology, including AI, symplr achieved significant efficiencies and enhanced the quality of its products and customer experiences.
"2025 has already been a pivotal year for symplr as we focus on solving some of healthcare's most complex operational challenges through the newly launched symplr Operations Platform," said
Applicants are evaluated and selected by a panel of external judges focused on assessing hallmarks of excellence in four key areas: strategy, ability to execute, corporate culture, and governance/financial performance. They join a global ecosystem of honorees from more than 44 countries recognized by the Best Managed Companies program.
Hear from symplr's CEO, BJ Schaknowski, on what this recognition means for the company, its employees, and the future of healthcare operations at www.symplr.com/us-best-managed-company.
About symplr
symplr is a leader in enterprise healthcare operations software and services with a first-of-its-kind operations platform. Trusted in 9 of 10 U.S. hospitals and 400+
About the Best Managed Companies Program
The Best Managed Companies program is a mark of excellence for private companies.
View original content to download multimedia:https://www.prnewswire.com/news-releases/symplr-earns-us-best-managed-company-designation-for-second-consecutive-year-302454840.html
SOURCE symplr
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- aytm Publishes First Quarterly Data Quality Benchmark Report, Setting the Standard for Transparency in Survey Research
- Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition
- Transformworks Named an OpenAI Select Partner
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share